Connect with us

Hi, what are you looking for?

Economy

Brazil sees record COVID-19 deaths as pot-bangers jeer Bolsonaro speech

RIO DE JANEIRO — Brazil suffered a record 3,251 coronavirus disease 2019 (COVID-19) deaths on Tuesday, as pot-banging protests erupted across the country during an address by President Jair Bolsonaro in which he defended his pandemic response and pledged to ramp up vaccinations.

The new record number of daily deaths underlines the scale of Brazil’s outbreak, which is spiraling out of control thanks to a lumpy vaccine rollout and a messy patchwork of public health restrictions that are pushing the country’s hospitals to the breaking point.

Mr. Bolsonaro is under mounting pressure to control the outbreak, after repeatedly playing down the virus, sowing doubts about vaccines and fighting state and local lockdown measures.

In his brief televised address, Mr. Bolsonaro said his government had never failed to adopt measures to combat the pandemic and said he would make 2021 the year of vaccinations.

However, in cities across Brazil, loud pot-banging protests echoed through the night as many voiced their anger at his handling of an outbreak that has killed nearly 300,000 people.

Earlier on Tuesday, Mr. Bolsonaro swore in cardiologist Marcelo Queiroga as his fourth health minister since the pandemic began, in a closed ceremony. Tapped by Mr. Bolsonaro on Mar. 15, Mr. Queiroga replaced Eduardo Pazuello, an active-duty army general who has overseen most of the pandemic response.

It remains to be seen what path Mr. Queiroga will chart as health minister. Mr. Pazuello’s two predecessors both left government after clashing with Mr. Bolsonaro’s views on COVID-19.

Mr. Bolsonaro has gained international notoriety for his efforts to fight lockdowns, dismiss mask mandates and advocate unproven remedies such as hydroxychloroquine.

On Tuesday, he received a fresh setback when Brazil’s Supreme Court refused to hear his appeal against several states’ measures restricting economic activity to slow contagion, according to a document seen by Reuters.

Mr. Bolsonaro also received a setback when the country’s Supreme Court ruled his fierce political rival, former leftist President Luiz Inacio Lula da Silva, had not been treated impartially in graft probes that led to his convictions. The decision appears certain to ensure the far-right former army captain will face Mr. Lula in next year’s presidential vote in which they are both expected to run.

VACCINE WOES
Despite Mr. Bolsonaro’s newfound focus on vaccines, the reality remains challenging for Brazil.

The country’s federally funded Fiocruz Institute, which is producing the AstraZeneca vaccine that serves as the cornerstone of the government’s vaccine rollout, said on Tuesday it would only deliver 18.8 million shots in April, down from an initial forecast of 30 million.

Only 2.6% of Brazilian adults have so far received two vaccine doses, according to a Fiocruz survey, while 7.6% of the population, or 12.1 million people, have received one shot.

The World Health Organization’s (WHO) regional director for the Americas, Carissa Etienne, said on Tuesday the virus is surging “dangerously” across Brazil, and urged all Brazilians to adopt preventive measures to stop the spread. — Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

The national pig herd has lost-one tenth of all sows over the last six months, farmers’ associations have revealed, after breeders were forced into...

Investing

EasyJet plunged £213 million into the red in the Christmas quarter and is still burning through £150 million in cash each month, putting its...

Investing

A new range of healthy yet indulgent cookies will launch in Booths this month for just £1 per pack with the UK-born snacks by...

Investing

Payments firm Checkout.com has raised $1bn (£730m), giving it a $40bn (£29bn) valuation and crowning it the UK’s most valuable private fintech. The London-headquartered...

Investing

Sylvera, a UK-based startup that provides ratings for carbon offsets, has raised $32.6m (£24.1m) in a Series A funding round to accelerate and expand...

Investing

UK-based fintech Everything has raised €2m (£1.67m) to reinvent a decades-old financial product: premium bonds. The raise was led by a group of angel...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.